- Home
- IGC vs FGF Comparison
IGC vs FGF Comparison
Compare IGC & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- FGF
- Stock Information
- Founded
- IGC 2005
- FGF 2012
- Country
- IGC United States
- FGF United States
- Employees
- IGC N/A
- FGF N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- FGF Property-Casualty Insurers
- Sector
- IGC Health Care
- FGF Finance
- Exchange
- IGC Nasdaq
- FGF Nasdaq
- Market Cap
- IGC 29.4M
- FGF 29.0M
- IPO Year
- IGC N/A
- FGF N/A
- Fundamental
- Price
- IGC $0.31
- FGF $18.53
- Analyst Decision
- IGC Strong Buy
- FGF
- Analyst Count
- IGC 2
- FGF 0
- Target Price
- IGC $3.88
- FGF N/A
- AVG Volume (30 Days)
- IGC 392.1K
- FGF 17.9K
- Earning Date
- IGC 02-18-2025
- FGF 03-21-2025
- Dividend Yield
- IGC N/A
- FGF N/A
- EPS Growth
- IGC N/A
- FGF N/A
- EPS
- IGC N/A
- FGF N/A
- Revenue
- IGC $1,236,000.00
- FGF $22,351,000.00
- Revenue This Year
- IGC N/A
- FGF N/A
- Revenue Next Year
- IGC $18.34
- FGF N/A
- P/E Ratio
- IGC N/A
- FGF N/A
- Revenue Growth
- IGC 1.64
- FGF N/A
- 52 Week Low
- IGC $0.26
- FGF $14.21
- 52 Week High
- IGC $0.91
- FGF $38.40
- Technical
- Relative Strength Index (RSI)
- IGC 52.84
- FGF 36.97
- Support Level
- IGC $0.26
- FGF $17.91
- Resistance Level
- IGC $0.34
- FGF $21.40
- Average True Range (ATR)
- IGC 0.02
- FGF 1.04
- MACD
- IGC 0.01
- FGF -0.16
- Stochastic Oscillator
- IGC 65.88
- FGF 17.49
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About FGF FG Financial Group Inc. (NV)
Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segment includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.